A new study has been conducted to evaluate the stability of 10 most commonly used API's compounded in SyrSpend® SF:
Atropine Sulphate 0.1mg/mL
Levofloxacin 50.0 mg, mL
Metoprolol Tartrate 10.0 mg, mL
Nitrofurantoin 2.0mg, mL
Ondansetron Hydrochloride 0.8 mg/mL
Oxandrolone 3.0 mg/mL
All suspensions were stored at both controlled refrigeration and controlled room temperatures. The stability for each suspension was verified by high-performance liquid chromotography to measure to quantity of the API remaining over a certain period of time.
The study found that the suspensions had reached beyond-use-date past 90 days, suggesting that SyrSpend® SF PH4 is stable when used with the different pharmacological classes of active pharmaceutical ingredients.
View the entire article below.